Early identification of severe Mycoplasma pneumoniae pneumonia in children: A retrospective model development study

Zijuan Dong1, Xiaojuan Zhang1, Lina Gu1

  • 1Department of Infectious Disease, Affiliated Children's Hospital of Jiangnan University, Wuxi Children's Hospital, 299-1 Qingyang Road, Wuxi, 214023, China.

Respiratory Medicine
|March 8, 2026
PubMed
Abstract

Insights

A recent outbreak saw nearly one-third of pediatric Mycoplasma pneumoniae pneumonia (MPP) cases become severe. A new nomogram using admission data helps predict severe MPP (SMPP) in children, aiding early treatment.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Clinical Epidemiology

Background:

  • A significant increase in pediatric Mycoplasma pneumoniae pneumonia (MPP) cases has been noted in China since mid-2023.
  • There is a current lack of effective tools for the early identification of severe pediatric MPP (SMPP).

Purpose of the Study:

  • To identify independent predictors of severe pediatric MPP (SMPP).
  • To develop and validate a predictive nomogram for SMPP risk in hospitalized children.

Main Methods:

  • Retrospective analysis of 908 children (≤ 14 years) hospitalized with MPP.
  • Comparison of demographic, clinical, laboratory, and medication data between severe MPP (SMPP) and non-SMPP groups.
  • Development of a five-parameter nomogram using logistic regression and internal validation via bootstrap resampling.

Main Results:

  • Severe pediatric MPP (SMPP) constituted 30.5% of all admissions.
  • Independent predictors for SMPP included higher neutrophil percentage, older age, prolonged pre-admission azithromycin exposure, higher peak temperature, and elevated lactate dehydrogenase (LDH).
  • The developed nomogram demonstrated good predictive accuracy with an AUC of 0.75.

Conclusions:

  • Nearly one-third of pediatric MPP admissions during the 2023-2024 outbreak progressed to severe disease.
  • A five-parameter nomogram utilizing routine admission data offers reliable risk stratification for SMPP.
  • The nomogram may support timely clinical decision-making, though external validation and macrolide resistance assessment are needed.